LFCR
Price
$7.55
Change
-$0.39 (-4.91%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
281.68M
27 days until earnings call
PRFX
Price
$1.42
Change
-$0.20 (-12.35%)
Updated
Sep 5 closing price
Capitalization
3.27M
68 days until earnings call
Interact to see
Advertisement

LFCR vs PRFX

Header iconLFCR vs PRFX Comparison
Open Charts LFCR vs PRFXBanner chart's image
Lifecore Biomedical
Price$7.55
Change-$0.39 (-4.91%)
Volume$650
Capitalization281.68M
PainReform
Price$1.42
Change-$0.20 (-12.35%)
Volume$460.2K
Capitalization3.27M
LFCR vs PRFX Comparison Chart in %
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. PRFX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Buy and PRFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (LFCR: $7.94 vs. PRFX: $1.42)
Brand notoriety: LFCR and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 257% vs. PRFX: 11%
Market capitalization -- LFCR: $281.68M vs. PRFX: $3.27M
LFCR [@Pharmaceuticals: Generic] is valued at $281.68M. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $3.27M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, LFCR is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 5 TA indicator(s) are bullish while PRFX’s TA Score has 4 bullish TA indicator(s).

  • LFCR’s TA Score: 5 bullish, 5 bearish.
  • PRFX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than PRFX.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а +4.20% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Reported Earning Dates

LFCR is expected to report earnings on Oct 02, 2025.

PRFX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($282M) has a higher market cap than PRFX($3.27M). LFCR YTD gains are higher at: 6.864 vs. PRFX (-57.675). LFCR has higher annual earnings (EBITDA): -8.81M vs. PRFX (-17.81M). PRFX has less debt than LFCR: PRFX (59K) vs LFCR (131M). LFCR has higher revenues than PRFX: LFCR (129M) vs PRFX (0).
LFCRPRFXLFCR / PRFX
Capitalization282M3.27M8,621%
EBITDA-8.81M-17.81M49%
Gain YTD6.864-57.675-12%
P/E Ratio51.23N/A-
Revenue129M0-
Total Cash8.27MN/A-
Total Debt131M59K222,034%
FUNDAMENTALS RATINGS
LFCR: Fundamental Ratings
LFCR
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LFCRPRFX
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BYRN19.620.68
+3.59%
Byrna Technologies
YELP32.000.30
+0.95%
YELP
SCI77.82-0.79
-1.00%
Service Corp
AKAN3.45-0.09
-2.54%
Akanda Corp
BYFC7.75-0.26
-3.20%
Broadway Financial Corp

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.98%
NBIX - LFCR
36%
Loosely correlated
+3.15%
SHPH - LFCR
31%
Poorly correlated
-5.52%
TKNO - LFCR
27%
Poorly correlated
-0.24%
TLRY - LFCR
27%
Poorly correlated
-2.95%
ALKS - LFCR
26%
Poorly correlated
-3.60%
More